Elevance Health
1,447 hedge funds and large institutions have $97B invested in Elevance Health in 2022 Q3 according to their latest regulatory filings, with 111 funds opening new positions, 563 increasing their positions, 503 reducing their positions, and 89 closing their positions.
25% more first-time investments, than exits
New positions opened: 111 | Existing positions closed: 89
12% more repeat investments, than reductions
Existing positions increased: 563 | Existing positions reduced: 503
0% more funds holding
Funds holding: 1,442 → 1,447 (+5)
0.27% more ownership
Funds ownership: 88.64% → 88.92% (+0.27%)
5% less call options, than puts
Call options by funds: $614M | Put options by funds: $646M
6% less capital invested
Capital invested by funds: $103B → $97B (-$6.21B)
7% less funds holding in top 10
Funds holding in top 10: 69 → 64 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$617M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$417M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$244M |
| 4 |
Amundi
Paris,
France
|
+$221M |
| 5 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
+$187M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$352M |
| 2 |
BlackRock
New York
|
-$346M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$309M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$231M |
| 5 |
SCM
Steadfast Capital Management
New York
|
-$215M |
ELV Hedge Fund Activity: Q3 2022 in Review
1,447 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q3 2022, worth a combined $97B — down 6% from $103B a quarter earlier.
Buyers outnumbered sellers: 111 funds opened new ELV positions and 89 closed out — a net gain of 22 holders — while 563 added to existing stakes and 503 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $617M. The largest seller was DZ Bank, cutting an estimated $352M.
- 1,447 institutional investors held Elevance Health (ELV) as of Q3 2022, up from 1,442 in Q2 2022.
- Funds reported $97B of Elevance Health stock for Q3 2022, down 6% quarter-over-quarter.
- 111 funds opened new Elevance Health positions in Q3 2022 and 89 closed out, a net change of +22 holders.
- The largest Elevance Health buyer in Q3 2022 was T. Rowe Price Associates, an estimated $617M added.
- The largest Elevance Health seller in Q3 2022 was DZ Bank, an estimated $352M sold.
Based on aggregated 13F filings for Q3 2022.